Literature DB >> 22144188

Controlling miRNA regulation in disease.

Willemijn M Gommans1, Eugene Berezikov.   

Abstract

Our understanding of the importance of noncoding RNA molecules is steadily growing. One such important class of RNA molecules are microRNAs (miRNAs). These tiny RNAs fulfill important functions in cellular behavior by influencing the protein output levels of a high variety of genes through the regulation of target messenger RNAs. Moreover, miRNAs have been implicated in a wide range of diseases. In pathological conditions, the miRNA expression levels can be altered due to changes in the transcriptional or posttranscriptional regulation of miRNA expression. On the other side, mRNA molecules might be able to escape the regulation by miRNAs. In this review, we give an overview on how miRNA biogenesis can be altered in disease as well as how mRNAs can avoid the regulation by miRNAs. The interplay between these two processes defines the final protein output in a cell, and thus the normal or pathological cellular phenotype.

Mesh:

Substances:

Year:  2012        PMID: 22144188     DOI: 10.1007/978-1-61779-427-8_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

Review 1.  Epigenetic influences on genetically triggered thoracic aortic aneurysm.

Authors:  Stefanie S Portelli; Elizabeth N Robertson; Cassandra Malecki; Kiersten A Liddy; Brett D Hambly; Richmond W Jeremy
Journal:  Biophys Rev       Date:  2018-09-28

Review 2.  MicroRNAs and Cardiac Regeneration.

Authors:  Conrad P Hodgkinson; Martin H Kang; Sophie Dal-Pra; Maria Mirotsou; Victor J Dzau
Journal:  Circ Res       Date:  2015-05-08       Impact factor: 17.367

3.  Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.

Authors:  Yong Yang; Peng Zhang; Yanfeng Zhao; Jie Yang; Gening Jiang; Jie Fan
Journal:  Cancer Biol Ther       Date:  2015-10-22       Impact factor: 4.742

4.  MicroRNA-124 negatively regulates LPS-induced TNF-α production in mouse macrophages by decreasing protein stability.

Authors:  Yang Sun; Zhen Qin; Qi Li; Jing-Jing Wan; Ming-He Cheng; Peng-Yuan Wang; Ding-Feng Su; Jian-Guang Yu; Xia Liu
Journal:  Acta Pharmacol Sin       Date:  2016-04-11       Impact factor: 6.150

5.  miRNA and mRNA cancer signatures determined by analysis of expression levels in large cohorts of patients.

Authors:  Sohila Zadran; F Remacle; R D Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

Review 6.  Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease.

Authors:  Shan Jiang; Manyu Luo; Xue Bai; Ping Nie; Yuexin Zhu; Hangxi Cai; Bing Li; Ping Luo
Journal:  J Cell Commun Signal       Date:  2022-01-18       Impact factor: 5.908

7.  MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.

Authors:  Zhiqiang Zheng; Dongsheng Yan; Xiaoyan Chen; He Huang; Ke Chen; Guangjing Li; Linglin Zhou; Dandan Zheng; LiLi Tu; Xiang Da Dong
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

8.  Serum MicroRNAs as Potential Biomarkers of AMD.

Authors:  Maciej Szemraj; Anna Bielecka-Kowalska; Katarzyna Oszajca; Marta Krajewska; Roman Goś; Piotr Jurowski; Michał Kowalski; Janusz Szemraj
Journal:  Med Sci Monit       Date:  2015-09-14

9.  Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.

Authors:  D Sun; R Layer; A C Mueller; M A Cichewicz; M Negishi; B M Paschal; A Dutta
Journal:  Oncogene       Date:  2013-03-18       Impact factor: 9.867

Review 10.  Placental disease and the maternal syndrome of preeclampsia: missing links?

Authors:  Dionne Tannetta; Ian Sargent
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.